Z103204-1-O |
A427 (cluster #1 Of 4), Other |
Other |
5130 |
0.39 |
Functional ≤ 10μM
|
Z50425-3-O |
Plasmodium Falciparum (cluster #3 Of 22), Other |
Other |
10000 |
0.37 |
Functional ≤ 10μM
|
Z50587-3-O |
Homo Sapiens (cluster #3 Of 9), Other |
Other |
3240 |
0.40 |
Functional ≤ 10μM
|
Z80008-2-O |
5637 (Epithelial Bladder Carcinoma Cells) (cluster #2 Of 3), Other |
Other |
310 |
0.48 |
Functional ≤ 10μM
|
Z80035-2-O |
B16 (Melanoma Cells) (cluster #2 Of 7), Other |
Other |
2200 |
0.42 |
Functional ≤ 10μM
|
Z80064-7-O |
CCRF-CEM (T-cell Leukemia) (cluster #7 Of 9), Other |
Other |
6170 |
0.38 |
Functional ≤ 10μM
|
Z80112-1-O |
DAN-G (cluster #1 Of 2), Other |
Other |
2650 |
0.41 |
Functional ≤ 10μM
|
Z80156-4-O |
HL-60 (Promyeloblast Leukemia Cells) (cluster #4 Of 12), Other |
Other |
2040 |
0.42 |
Functional ≤ 10μM
|
Z80193-10-O |
L1210 (Lymphocytic Leukemia Cells) (cluster #10 Of 12), Other |
Other |
981 |
0.44 |
Functional ≤ 10μM
|
Z80211-2-O |
LoVo (Colon Adenocarcinoma Cells) (cluster #2 Of 5), Other |
Other |
4900 |
0.39 |
Functional ≤ 10μM
|
Z80224-1-O |
MCF7 (Breast Carcinoma Cells) (cluster #1 Of 14), Other |
Other |
5700 |
0.39 |
Functional ≤ 10μM
|
Z80231-2-O |
MCF7S (Breast Carcinoma Cells) (cluster #2 Of 2), Other |
Other |
300 |
0.48 |
Functional ≤ 10μM
|
Z80285-2-O |
MOLT-4 (Acute T-lymphoblastic Leukemia Cells) (cluster #2 Of 4), Other |
Other |
3240 |
0.40 |
Functional ≤ 10μM
|
Z80362-3-O |
P388 (Lymphoma Cells) (cluster #3 Of 8), Other |
Other |
220 |
0.49 |
Functional ≤ 10μM
|
Z80473-1-O |
SISO (cluster #1 Of 2), Other |
Other |
1000 |
0.44 |
Functional ≤ 10μM
|
Z80604-1-O |
YAPC (cluster #1 Of 2), Other |
Other |
5950 |
0.39 |
Functional ≤ 10μM
|
Z80807-1-O |
D283 Cell Line (cluster #1 Of 1), Other |
Other |
6800 |
0.38 |
Functional ≤ 10μM
|
Z80874-3-O |
CEM (T-cell Leukemia) (cluster #3 Of 7), Other |
Other |
2500 |
0.41 |
Functional ≤ 10μM
|
Z80887-1-O |
H2981 Cell Line (cluster #1 Of 1), Other |
Other |
5000 |
0.39 |
Functional ≤ 10μM
|
Z81072-6-O |
Jurkat (Acute Leukemic T-cells) (cluster #6 Of 10), Other |
Other |
2200 |
0.42 |
Functional ≤ 10μM
|
Z81235-1-O |
M4Beu Cell Line (cluster #1 Of 1), Other |
Other |
1200 |
0.44 |
Functional ≤ 10μM
|
Z81247-2-O |
HeLa (Cervical Adenocarcinoma Cells) (cluster #2 Of 9), Other |
Other |
1900 |
0.42 |
Functional ≤ 10μM
|
Z81252-3-O |
MDA-MB-231 (Breast Adenocarcinoma Cells) (cluster #3 Of 11), Other |
Other |
5700 |
0.39 |
Functional ≤ 10μM
|
Z81338-1-O |
T-cells (cluster #1 Of 3), Other |
Other |
2200 |
0.42 |
Functional ≤ 10μM
|
Z80874-2-O |
CEM (T-cell Leukemia) (cluster #2 Of 4), Other |
Other |
2470 |
0.41 |
ADME/T ≤ 10μM
|
Z81325-1-O |
SR (Leukemia Cells) (cluster #1 Of 1), Other |
Other |
1860 |
0.42 |
ADME/T ≤ 10μM
|